Prognostic value of serum biological markers in patients with hepatocellular carcinoma

Clinical Cancer Research

Volumn 7, Issue 11, 2001, Pages 3504-3509

  Parasole, Rosanna ^a   Izzo, Francesco ^b   Perrone, Francesco ^d   Pignata, Sandro ^c   Galati, Maria Giulia ^e   Leonardi, Enrico ^a   Castiglione, Fabiana ^f   Orlando, Raffaele ^g   Castello, Giuseppe ^a   Esposito, Giuseppe ^e   Gallo, Ciro ^h   Daniele, Bruno ^c  

^a Div of Clin Immunology and Allergy   (Italy)

^b Surgical Oncology C   (Italy)

^c Clinical Trials Office   (Italy)

^d Ist Naz Stud/Cura Tum   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f Divisions of Gastroenterology   (Italy)

^g Infectious Diseases Clinic   (Italy)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; PROTEIN ANTIBODY; PROTEIN P53; PROTEIN P53 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASSAY; CANCER CLASSIFICATION; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL VEIN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

AGED; ANALYSIS OF VARIANCE; ANTIBODIES; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, INTERLEUKIN-2; SOLUBILITY; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035189701     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. The relationship between hepatocellular carcinoma and cirrhosis
2. Natural history of hepatocellular carcinoma and prognosis in relation to treatment
3. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
4. Transection of the oesophagus for bleeding oesophageal varices
5. Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma
6. How should patients with HCC be staged? Validation of a new prognostic system
7. Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis
8. Soluble interleukin-2 receptor levels in hepatocellular cancer: A more sensitive marker than α-fetoprotein
9. Role de l'interleukine 6 dans le carcinoma hepatocellulaire
10. Serum levels of IL-10, IL-15, and soluble tumor necrosis factor-α (TNF-α) receptors in type C chronic liver disease
11. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma
12. Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma
13. p53 antibodies in patients with various types of cancer: Assay, identification, and characterization
14. Non-parametric estimation from incomplete observation
15. Evaluation of survival data and two new rank order statistics arising in its consideration
16. Regression models and life tables
17. The clinical significance of p53 mutation in hepatocellular carcinomas from Japan
18. Assessment of the biological malignancy of hepatocellular carcinoma: Relationship to clinicopathological factors and prognosis
19. Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients
20. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
21. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene family
22. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)
23. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity
24. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by γ-interferon enhances spontaneous and bispecific anti-CD3 × antitumor antibody-directed lymphokine-activated killer cell cytotoxicity
25. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: Further evidence for a third ligand for leukocyte function-associated antigen-1
26. Modulation by cytokines on the surface expression and shedding of intercellular adhesion molecule-1 (ICAM-1) in human liver cancer cell lines
27. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α
28. Serum levels of IL-2 receptor as a tumor markers in patients with hairy cell leukemia
29. Correlation of soluble interleukin-2 receptor levels with severity of chronic hepatitis C virus liver injury and development of hepatocellular cancer
30. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer